All Articles

Facing economic fallout and service crises, over 1,900 municipal leaders will press provincial officials for concrete action at a critical conference.

A new federal funding announcement in Calgary aims to bolster Canada's power grid, focusing on clean energy, reliability, and affordability for all Canadians.

Rubico Inc.'s new $4 million offering sent its stock tumbling amid severe dilution concerns and red flags over its financial health and ability to fund growth.

Office leasing rose 5% in 2025, but a closer look reveals a fractured recovery, with tech hubs booming while others lag and companies shrink their footprints.

Prescient's acquisition of Uptake creates an integrated giant in healthcare consulting. What does this mean for the industry, clients, and patient outcomes?

Kara Hurst brings corporate scaling expertise from Amazon to Water.org, aiming to accelerate market-driven solutions for the global water crisis.

Major drill results in New Brunswick reveal a rich antimony deposit, a key step in challenging China and Russia's grip on this strategic mineral supply.

With a major Series B led by IDG Capital, PhotonPay is accelerating its mission to re-architect global payments with a stablecoin-native infrastructure.

Appalachian Dairy Farmers Cooperative announces a landmark management transition to ensure stability and growth for its members in a volatile market.

At CES 2026, Jinxin Technology unveiled NAMI INSIGHT One, AI-powered learning glasses aiming to revolutionize education. But can it overcome the hurdles?

Private equity giant Platinum Equity invests in century-old Norton Packaging, signaling a major growth push in the resilient rigid packaging sector.

With new funding, Major Medical Devices is advancing a novel AAA repair device that uses arm access, promising safer procedures and wider patient eligibility.

Prescryptive and Ilant Health unveil a direct-to-employer model for obesity drugs, promising transparent pricing and better clinical outcomes for employers.

Akari Therapeutics is advancing a new class of cancer drugs. Its unique PH1 payload kills tumors and activates the immune system, setting up a pivotal 2026.

With a new $1.6B valuation led by T. Rowe Price, Hadrian is scaling its AI-powered factories to spearhead America's industrial and defense resurgence.

After a year of scrutiny, a former Urban League leader invests in the aspiring minority-controlled stock exchange, validating its mission for structural change.

One year after devastating wildfires, a $1M Bank of America grant is jumpstarting the rebuild of a beloved community YMCA, a symbol of hope and recovery.

Health Canada uncovers counterfeit erectile dysfunction drugs in Mississauga, warning of life-threatening dangers and a compromised supply chain.

A new collaboration between the Global Alzheimer's Platform and Alamar Biosciences aims to revolutionize diagnosis with ultra-sensitive blood tests for all.

Amid rising regulatory pressure, dxFeed's flawless performance in a critical industry-wide disaster recovery test sets a new benchmark for data reliability.